Preemptive analgesia I: physiological pathways and pharmacological modalities

Crile GW, Lower WE. Anoci-Association. Philadelphia: Saunders, 1914: 223–5. Kehlet H. General vs. regional anesthesia.In: Rogers MC, Tinker JH, Covino BG, Longnecker DE (Eds.) Principles and Practice of Anesthesiology. St. Louis: Mosby, 1993: 1218–34. Mendell LM. Physiological properties of unmyelinated fiber projection to the spinal cord. Exp Neurol 1966; 16: 316–32. Birrell GJ, McQueen DS, Iggo A, Coleman RA, Grubb BD. PGI2-induced activation and sensitization of articular mechanonociceptors. Neurosci Lett 1991; 124: 5–8. Levine JD, Fields HL, Basbaum AI. Peptides and the primary afferent nociceptor. J Neurosci 1993; 13: 2273–86. Cohen RH, Perl ER. Contributions of arachidonic acid derivatives and substance P to the sensitization of cutaneous nociceptors. J Neurophysiol 1990; 64: 457–64. Walker K, Perkins M, Dray A. Kinins and kinin receptors in the nervous system. Neurochem Int 1995; 26: 17–26. Dray A. Inflammatory mediators of pain. Br J Anaesth 1995; 75: 125–31. Suzuki H. Recent topics in the management of pain: development of the concept of preemptive analgesia. Cell Transplant 1995; 4(Suppl. 1): S3–6. Lynn B. Neurogenic inflammation. Skin Pharmacol 1988; 1: 217–24. Simone DA, Alreja M, LaMotte RH. Psychophysical studies of the itch sensation and itchy skin (”alloknesis”) produced by intracutaneous injection of histamine. Somatosens Mot Res 1991; 8: 271–9. Rang HP, Bevan S, Dray A. Nociceptive peripheral neurons: cellular properties.In: Wall PD, Melzack R (Eds.). Textbook of Pain, 3rd ed. Edinburgh: Churchill Livingstone, 1994: 57–78. Capasso F, Dunn CJ, Tamamoto S, Willoughby DA, Giroud JP. Further studies on carrageenan-induced pleurisy in rats. J Pathol 1975; 116: 117–24. Garcia Lente J, Hamamura L, Leite MP, Rocha e Silva M. Pharmacological analysis of the acute inflammatory process induced in the rat’s paw by local injection of carrageenin and by heating. Br J Pharmacol 1973; 48: 88–96. Holthusen H, Arndt JO. Nitric oxide evokes pain in humans on intracutaneous injection. Neurosci Lett 1994; 165: 71–4. Wall PD. The dorsal horn.In: Wall PD, Melzack R (Eds). Textbook of Pain, 2nd ed. Edinburgh: Churchill Livingstone; 1994: 102–12. Murase K, Randic M. Actions of substance P on rat spinal dorsal horn neurones. J Physiol (Lond) 1984; 346: 203–17. Skofitsch G, Jacobowitz DM. Calcitonin gene-related peptide coexists with substance P in capsaicin sensitive neurons and sensory ganglia of the rat. Peptides 1985; 6: 747–54. Schaible H-G, Freudenberger U, Neugebauer V, Stiller RU. Intraspinal release of immunoreactive calcitonin gene-related peptide during development of inflammation in the joint in vivo — a study with antibody microprobes in cat and rat. Neuroscience 1994; 62: 1293–305. Schneider SP, Perl ER. Selective excitation of neurons in the mammalian spinal dorsal horn by aspartate and glutamate in vitro: correlation with location and excitatory input. Brain Res 1985; 360: 339–43. Kangrga I, Larew JSA, Randic M. The effects of substance P and calcitonin gene-related peptide on the efflux of endogenous glutamate and aspartate from the rat spinal dorsal horn in vitro. Neurosci Lett 1990; 108: 155–60. Willcockson WS, Chung JM, Hori Y, Lee KH, Willis WD. Effects of iontophoretically released amino acids and amines on primate spinothalamic tract cells. J Neurosci 1984; 4: 732–40. Dougherty PM, Willis WD. Enhancement of spinothalamic neuron responses to chemical and mechanical stimuli following combined micro-iontophoretic application of N-methyl-D-aspartic acid and substance P. Pain 1991; 47: 85–93. Coderre TJ, Katz J, Vaccarino AL, Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 1993; 52: 259–85. Tolle TR, Castro-Lopes JM, Evan G, Zieglgansberger W. C-fos induction in the spinal cord following noxious stimulation: prevention by opiates but not by NMDA antagonists.In: Bond MR, Chariton JE, Woolf CJ (Eds). Proceedings of the VIth World Congress on Pain. Elsevier Science BV, 1991: 299–305. Willis WD Jr. Ascending somatosensory systems.In: Yaksh TL (Ed.). Spinal Afferent Processing. New York: Plenum Press, 1986: 398–416. Melzack R, Casey KL. Sensory, motivational, and central control determinants of pain. A new conceptual model.In: Kenshalo DR (Ed.). The Skin Senses. Illinois: Thomas, 1968: 423–39. Bowsher D. Role of the reticular formation in responses to noxious stimulation. Pain 1976; 2: 361–78. Price DD, Dubner R, Hu JW. Trigeminothalamic neurons in nucleus caudalis responsive to tactile, thermal, and nociceptive stimulation of monkey’s face. J Neurophysiol 1976; 39: 936–53. Jensen TS, Yaksh TL. Brainstem excitatory amino acid receptors in nociception: microinjection mapping and pharmacological characterization of glutamate-sensitive sites in the brainstem associated with algogenic behavior. Neuroscience 1992; 46: 535–47. Kikuchi H, Kitahata IM, Collins JG, Kawahara M, Nio K. Halothane-induced changes in neuronal activity of cells of the nucleus reticularis gigantocellularis of the cat. Anesth Analg 1980; 59: 897–901. Mosso JA, Kruger L. Spinal trigeminal neurons excited by noxious and thermal stimuli. Brain Res 1972; 38: 206–10. Ohtani M, Kikuchi H, Kitahata LM, et al. Effects of ketamine on nociceptive cells in the medial medullary reticular formation of the cat. Anesthesiology 1979; 51: 414–7. Yuge O, Kitahata LM, Collins JG, et al. Fentanyl and alfentanil suppress brainstem pain transmission. Anesth Analg 1985; 64: 597–600. Sherrington SC. The Integrative Action of the Nervous System. New York: C. Scribner & Son, 1906. Besson J-M, Chaouch A. Peripheral and spinal mechanisms of nociception. Physiol Rev 1987; 67: 67–186. Evans RH. The pharmacology of segmental transmission in the spinal cord. Prog Neurobiol 1989; 33: 255–79. Fields HL, Heinricher MM, Mason P. Neurotransmitters in nociceptive modulatory circuits. Ann Rev Neurosci 1991; 14: 219–45. Yaksh TL. Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists. Pain 1989; 37: 111–23. Dickenson AH. Spinal cord pharmacology of pain. Br J Anaesth 1995; 75: 193–200. Mollenholt P, Post C, Rawal N, Freedman J, Hokfelt T, Paulsson I. Antinociceptive and ‘neurotoxic’ actions of somatostatin in rat spinal cord after intrathecal administration. Pain 1988; 32: 95–105. Woolf CJ, Chong M-S. Preemptive analgesia—treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg 1993; 77: 362–79. Willis WD Jr, Coggeshall RE. Sensory Mechanisms of the Spinal Cord, 2nd ed. New York: Plenum, 1991. Hardy JD, Wolff HG, Goodell H. Experimental evidence on the nature of cutaneous hyperalgesia. J Clin Invest 1950; 29: 115–40. LaMotte RH, Shain CN, Simone DA, Tsai EFP. Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms. J Neurophysiol 1991; 66: 190–211. Raja SN, Campbell JN, Meyer RA. Evidence for different mechanisms of primary and secondary hyperalgesia following heat injury to the glabrous skin. Brain 1984; 107(Pt 4): 1179–88. Baumann TK, Simone DA, Shain CN, LaMotte RH. Neurogenic hyperalgesia: the search for the primary cutaneous afferent fibers that contribute to capsaicininduced pain and hyperalgesia. J Neurophysiol 1991; 66: 212–27. LaMotte RH, Lundberg LER, Torebjork HE. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin. J Physiol (Lond) 1992; 448: 749–64. Simone DA, Sorkin LS, Oh U, et al. Neurogenic hyperalgesia: central neural correlates in responses of spinothalamic tract neurons. J Neurophysiol 1991; 66: 228–46. Torebjork HE, Lundberg LER, LaMotte RH. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J Physiol (Lond) 1992; 448: 765–80. Kitahata LM. Pain pathways and transmission. Yale J Biol Med 1993; 66: 437–42. Dahl JB, Kehlet H. Non-steroidal anti-inflammatory drugs: rationale for use in severe postoperative pain. Br J Anaesth 1991; 66: 703–12. Malmberg AB, Yaksh TL. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther 1992; 263: 136–46. McCormack K. The spinal actions of nonsteroidal anti-inflammatory drugs and the dissociation between their anti-inflammatory and analgesic effects. Drugs 1994; 47(Suppl 5): 28–45; Discussion 46–7. Besse D, Lombard M-C, Zajac J-M, Roques BP, Besson JM. Pre- and postsynaptic location of mu, delta and kappa opioid receptors in the superficial layers of the dorsal horn of the rat spinal cord. Prog Clin Biol Res 1990; 328: 183–6. Uhl GR, Childers S, Pasternak G. An opiate-receptor gene family reunion. Trends Neurosci 1994; 17: 89–93. Dickenson AH, Sullivan AF. Electrophysiological studies on the effects of intrathecal morphine on nociceptive neurones in the rat dorsal horn. Pain 1986; 24: 211–22. Kangrga I, Randic M. Outflow of endogenous aspartate and glutamate from the rat spinal dorsal horn in vitro by activation of low- and high-threshold primary afferent fibers. Modulation by mu-opioids. Brain Res 1991; 553: 347–52. Pohl M, Lombard MC, Bourgoin S, et al. Opioid control of the in vitro release of calcitonin gene-related peptide from primary afferent fibres projecting in the rat cervical cord. Neuropeptides 1989; 14: 151–9. Dickenson AH. A cure for wind up: NMDA receptor antagonists as potential analgesics. Trends Pharmacol Sci 1990; 11: 307–9. Dickenson AH. Mechanisms of the analgesic actions of opiates and opioids. Br Med Bull 1991; 47: 690–702. Calderon SN, Rothman RB, Porreca F, et al. Probes for narcotic receptor mediated phenomena. 19. Synthesis of ( + )-4-[(alpha R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC 80): a highly selective, nonpeptide delta opioid receptor agonist. J Med Chem 1994; 37: 2125–8. Pleuvry BJ. Opioid receptors and their relevance to anaesthesia. Br J Anaesth 1993; 71: 119–26. Leighton GE, Rodriguez RE, Hill RG, Hughes J. kopioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat. Br J Pharmacol 1988; 93: 553–60. Millan MJ. k-opioid receptors and analgesia. Trends Pharmacol Sci 1990; 11: 70–6. Levine JD, Taiwo YO. Involvement of the mu-opiate receptor in peripheral analgesia. Neuroscience 1989; 32: 571–5. Taiwo YO, Levine JD. k- and delta-opioids block sympathetically dependent hyperalgesia. J Neurosci 1991; 11: 928–32. Dickenson AH, Sullivan AF. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation. Neuropharmacology 1987; 26: 1235–8. Dickenson AH, Sullivan AF. Differential effects of excitatory amino acid antagonists on dorsal horn nociceptive neurones in the rat. Brain Res 1990; 506: 31–9. Dray A, Urban L, Dickenson A. Pharmacology of chronic pain. Trends Pharmacol Sci 1994; 15: 190–7. Dubner R, Ruda MA. Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci 1992; 15: 96–103. McMahon SB, Lewin GR, Wall PD. Central hyperexcitability triggered by noxious inputs. Curr Opin Neurobiol 1993; 3: 602–10. Price DD, Mao J, Mayer DJ. Central neural mechanisms of normal and abnormal pain states.In: Fields HL, Liebeskind JC (Eds.). Pharmacological Approaches to the Treatment of Chronic Pain. Seattle: IASP Press, 1994: 61–84. Haley JE, Sullivan AF, Dickenson AH. Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res 1990; 518: 218–26. Davies SN, Lodge D. Evidence for involvement of N-methylaspartate receptors in ‘wind-up’ of class 2 neurones in the dorsal horn of the rat. Brain Res 1987; 424: 402–6. Eraser HM, Chapman V, Dickenson AH. Spinal local anaesthetic actions on afferent evoked responses and wind-up of nociceptive neurones in the rat spinal cord: combination with morphine produces marked potentiation of antinociception. Pain 1992; 49: 33–41. Wang Y-C, Su C-F, Lin M-T. The site and the mode of analgesic actions exerted by clonidine in monkeys. Exp Neurol 1985; 90: 479–88. Fielding S, Wilker J, Hynes M, Szewczak M, Novick WJ Jr, Lal H. A comparison of clonidine with morphine for antinociceptive and antiwithdrawal actions. J Pharmacol Exp Ther 1978; 207: 899–905. De Kock M, Crochet B, Morimont C, Scholtes J-L. Intravenous or epidural clonidine for intra- and post-operative analgesia. Anesthesiology 1993; 79: 525–31. Omote K, Kitahata LM, Collins JG, Nakatani K, Nakagawa I. Interaction between opiate subtype and alpha-2 adrenergic agonists in suppression of noxiously evoked activity of WDR neurons in the spinal dorsal horn. Anesthesiology 1991; 74: 737–43. Wilcox GL, Carlsson K-H, Jochim A, Jurna I. Mutual potentiation of antinociceptive effects of morphine and clonidine on motor and sensory responses in rat spinal cord. Brain Res 1987; 405: 84–93. Goyagi T, Nishikawa T. The addition of epinephrine enhances postoperative analgesia by intrathecal morphine. Anesth Analg 1995; 81: 508–13. Paalzow G. Development of tolerance to the analgesic effect of clonidine in rats. Cross-tolerance to morphine. Naunyn Schmiedebergs Arch Pharmacol 1978; 304: 1–4. Stevens CW, Monasky MS, Taksh TL. Spinal infusion of opiate and alpha-2 agonists in rats: tolerance and cross-tolerance studies. J Pharmacol Exp Ther 1988; 244: 63–70. Gold MS, Redmond DE Jr, Kleber HD. Clonidine blocks acute opiate-withdrawal symptoms. Lancet 1978; 2: 599–602. Gordh T Jr, Jansson I, Hartvig P, Gillberg PG, Post C. Interactions between noradrenergic and cholinergic mechanisms involved in spinal nociceptive processing. Acta Anaesthesiol Scand 1989; 33: 39–47. Detweiler DJ, Eisenach JC, Tong C, Jackson C. A cholinergic interaction in alpha 2 adrenoceptor-mediated antinociception in sheep. J Pharmacol Exp Ther 1993; 265: 536–42. Stanfa LC, Sullivan AF, Dickenson AH. Alterations in neuronal excitability and the potency of spinal mu, delta and kappa opioids after carrageenan-induced inflammation. Pain 1992; 50: 345–54. Stanfa L, Dickenson A, Xu XJ Wiesenfeld-Hallin Z. Cholecystokinin and morphine analgesia: variations on a theme. Trends Pharmacol Sci 1994; 15: 65–6. Zhou Y, Sun Y-H, Zhang Z-W, Han J-S. Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord. Eur J Pharmacol 1993; 234: 147–54. Moore PK, Wallace P, Gaffen Z, Hart SL, Babbedge RC. Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects. Br J Pharmacol 1993; 110: 219–24. Aanonsen LM, Wilcox GL. Muscimol, -aminobutyric acidA receptors and excitatory amino acids in the mouse spinal cord. J Pharmacol Exp Ther 1989; 248: 1034–8. Burch RM, Farmer SG, Steranka LR. Bradykinin receptor antagonists. Med Res Rev 1990; 10: 237–69. Dray A, Perkins M. Bradykinin and inflammatory pain. Trends Neurosci 1993; 16: 99–104. Taiwo YO, Fabian A, Pazoles CJ, Fields HL. Potentiation of morphine antinociception by monoamine reuptake inhibitors in the rat spinal cord. Pain 1985; 21: 329–37. Botney M, Fields HL. Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system. Ann Neurol 1983; 13: 160–4. Bouaziz H, Tong C, Eisenach JC. Postoperative analgesia from intrathecal neostigmine in sheep. Anesth Analg 1995; 80: 1140–4. Eisenach JC, Gebhart GF. Intrathecal amitriptyline. Antinociceptive interactions with intravenous morphine and intrathecal clonidine, neostigmine, and carbamylcholine in rats. Anesthesiology 1995; 83: 1036–45. Abram SE, Winne RP. Intrathecal acetyl cholinesterase inhibitors produce analgesia that is synergistic with morphine and clonidine in rats. Anesth Analg 1995; 81: 501–7. Svensson BA, Sottile A, Gordh T Jr. Studies on the development of tolerance and potential spinal neurotoxicity after chronic intrathecal carbachol-antinociception in the rat. Acta Anaesthesiol Scand 1991; 35: 141–7. Gillberg PG, Hartvig P, Gordh T, et al. Behavioral effects after intrathecal administration of cholinergic receptor agonists in the rat. Psychopharmacology (Berl) 1990; 100: 464–9. Welch SP, Dunlow LD. Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: a common mechanism of action? J Pharmacol Exp Ther 1993; 267: 390–9. Sawynok J, Sweeney MI, White TD. Classification of adenosine receptors mediating antinociception in the rat spinal cord. Br J Pharmacol 1986; 88: 923–30. Sosnowski M, Stevens CW, Taksh TL. Assessment of the role of A1/A2 adenosine receptors mediating the purine antinociception, motor and autonomic function in the rat spinal cord. J Pharmacol Exp Ther 1989; 250: 915–22.